Search clinical trials for: BMS-986189
Total 3177 results
-
CelgeneTerminated
-
Bristol-Myers SquibbExelixisTerminatedMetastatic Cancer | Advanced Solid CancersUnited States, Canada, France
-
Bristol-Myers SquibbCompletedHeart FailureFrance, Germany, Japan, Spain, United States, Argentina, Poland, Italy, Czechia, Greece, Netherlands, Canada, United Kingdom
-
Aegerion Pharmaceuticals, Inc.CompletedFamilial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Vanda PharmaceuticalsCompletedHealthy VolunteersUnited States
-
InspireMDCompletedMyocardial InfarctionPoland, South Africa
-
CelgeneNot yet recruitingRenal ImpairmentUnited States
-
Allyx TherapeuticsYale University; National Institute on Aging (NIA)RecruitingAlzheimer's DiseaseUnited States
-
Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products DevelopmentCompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
InspireMDWithdrawnST Segment Elevated Myocardial InfarctionUnited Kingdom
-
Aegerion Pharmaceuticals, Inc.University of Pennsylvania; Doris Duke Charitable FoundationCompletedHomozygous Familial HypercholesterolemiaUnited States
-
Bristol-Myers SquibbWithdrawnHepatitis C VirusUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBroad Solid TumorUnited States, Argentina, Australia, Canada, Chile, Japan, Romania, Singapore
-
Bluedrop Medical LimitedRecruitingDiabetic FootUnited States
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
Bristol-Myers SquibbRecruitingSystemic Lupus ErythematosusUnited States, Taiwan, Japan, United Kingdom, Brazil, Colombia, Poland, Puerto Rico, China, France, Chile, Australia, Mexico, Germany, Argentina, India, Spain, Romania, Ireland
-
R-PharmCompletedStomach NeoplasmsKorea, Republic of, Taiwan, Japan, Singapore, Hong Kong
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbTerminatedAlzheimer's DiseaseSweden, United States, Canada, Denmark, France, Finland
-
Bristol-Myers SquibbTerminatedNon Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedAlzheimer's Disease
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbCompletedHealthy Subjects and Atopic Dermatitis SubjectsUnited Kingdom
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedMelanoma | Skin CancerUnited States, Canada, Netherlands, Spain, Australia, Italy, Japan, Germany, Ireland, United Kingdom, Czechia, Switzerland, Poland, France, Greece, New Zealand
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisUnited States
-
Bristol-Myers SquibbClovis Oncology, Inc.CompletedAdvanced Gastric CancerUnited States, Israel, Netherlands, Canada, Italy, Australia, Germany, Singapore, Switzerland
-
Bristol-Myers SquibbCompletedHepatic ImpairmentUnited States
-
R-PharmCompletedMetastatic Pancreatic CancerUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
Bristol-Myers SquibbMedarexCompleted
-
Thomas Jefferson UniversityBristol-Myers SquibbActive, not recruitingLarynx | Squamous Cell Carcinoma | Lip | Oral Cavity Squamous Cell Carcinoma | PharynxUnited States
-
Bristol-Myers SquibbRecruitingAlzheimer Disease, Early OnsetUnited States, Australia, Belgium, Canada, France, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, United Kingdom
-
CelgeneRecruitingEosinophilic EsophagitisUnited States
-
The University of Hong KongNot yet recruiting
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsSpain
-
Bristol-Myers SquibbCompletedModerate Liver Impairment | Severe Liver ImpairmentUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedCongestive Heart Failure | Liver Dysfunction | Heart Decompensation | Cardiac Failure | Liver Insufficiency | Myocardial Failure | Hepatic FailureHungary, Poland
-
CelgeneRecruitingMultiple MyelomaAustria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom